20대 여성의 가다실 9가에 대한 지불의사액 추정 - CVM 이중양분선택형 이변량 프로빗 모형을 이용하여 - = Estimating the willingness to pay for Gadasil9 in women in their20s - Using double bounded dichotomous choice method and bivariate probit model -

다국어 초록 (Multilingual Abstract)

Research is actively being conducted in Korea to apply the Gadasil 9 vaccine to the national vaccination support project. Social interest in this is very high, but the cost-effectiveness varies from study to study. Until now, government-level studies have been conducted using costs such as treatment costs, time costs, and nursing costs. On the other hand, to measure the value that consumers give to Gadasil 9, this study aims to estimate the willingness to pay(WTP) using the Containing Valuation Method and to reveal the determinants that make consumers give high value. Since Gadasil 9 is an exclusive good whose price is determined by a monopoly company and is a type of medical service, this study adopted a double bound dichotomous choice method and a bivariate probit model. As a result of conducting CVM analysis, statistical significance was paid to the average monthly expenditure, the type of vaccine inoculated, the level of awareness of the efficacy of Gadasil 9, cervical cancer screening, and treatment costs, and a new direction can be presented. In addition, follow-up studies should be conducted considering the number of unvaccinated patients and the effect of re-vaccination of Gadasil 9 vaccine in vaccinated people.